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B Cell Hyperresponsiveness and Expansion of Mature
Follicular B Cells but Not of Marginal Zone B Cells in
NFATc2/c3 Double-Deficient Mice1
Devapriya Nandini Samanta,* Alois Palmetshofer,* Dragan Marinkovic,2‡ Thomas Wirth,‡
Edgar Serfling,3,4* and Lars Nitschke3,4†
Marginal zone (MZ) B cells and peritoneal B-1 cells provide a first defense system of thymus-independent Ab responses against
foreign pathogens and therefore share a number of functional properties. Recently, development of B-1a cells was shown to be
controlled by the transcription factor NFATc1. We show here that mice deficient for NFATc2 and c3 display a distinct lower
representation of MZ B cells, which is correlated with a reduced capturing of trinitrophenyl-Ficoll. In contrast, mature follicular
B cells from NFATc2/c3/ mice are strongly increased in number. NFATc2/c3/ B cells exhibit a marked increase in BCR-
induced intracellular Ca2 mobilization and proliferation. However, trinitrophenyl-Ficoll-specific IgM and IgG3 responses of
NFATc2/c3-deficient mice are intact, and chimeric mice reconstituted with NFATc2/3-deficient B cells show a normal number of
MZ B cells and normal BCR responses. These observations suggest that the strongly elevated Th2 cytokine milieu in NFATc2/
c3-deficient mice leads to a hyperactivation of mature, follicular B cells, whereas MZ B cells are less responsive to these
signals. The Journal of Immunology, 2005, 174: 4797–4802.
N uclear factor of activated T cell proteins represent a fam-ily of five transcription factors that share a highly con-served DNA-binding domain (1, 2). Among those, the
four genuine NFATc proteins share several conserved phosphor-
ylation motifs within their N-terminal regulatory domain. The
Ca2/calmodulin phosphatase calcineurin can bind to these motifs
and control NFAT activity (3). In both T and B lymphocytes, an
increase in intracellular-free Ca2 and calcineurin activity stimu-
lated by TCR or BCR signals leads to the rapid nuclear translo-
cation and activation of NFATs (1–3).
NFATc1, c2, and c3 are expressed in lymphoid cells where they
control the transcription of lymphokine genes, e.g., of IL-2, IL-3,
IL-4, IL-5, IFN-, and TNF- genes. In addition, several receptor
and ligand genes, e.g., the CD25, CD95, and CD154 genes, as well
as other genes controlling T cell activation, apoptosis, and cell
cycle, are regulated by NFATc proteins (1–3). Compared with the
well-studied role of NFAT factors in T lymphocytes, much less is
known about the function of NFATs in B lymphocytes, although
NFATs have been shown to be expressed in B cells at levels sim-
ilar to those in T cells (4). One NFAT target gene, which is ex-
pressed specifically in the subset of B-1a cells, is the CD5 gene
whose transcription is controlled by an upstream enhancer. The
activity of this enhancer is controlled by the binding of NFAT
factors to two sites, which are highly conserved between mouse
and human (5–7). Subsequent studies showed that NFATc1 is
more strongly expressed in B-1a cells than in B-2 cells and is
essential for the generation of peritoneal and splenic B1-a cells (8).
B-1 cells represent a special subset of B lymphocytes, which are
abundant in peritoneal and pleural cavities. During fetal develop-
ment, B-1 cells are the main B cell population. It had been as-
sumed that B-1 cells are derived exclusively from fetal precursor
cells, whereas B-2 cells were thought to be generated from adult
bone marrow (BM)5 cells only (9). However, experimental data
published recently indicate that splenic B cells can also be precur-
sors for B-1 cells (10). The BCR repertoire, the receptor density,
and the type of Ag contact appear to drive B-1 cell development
(11). B-1 cells share a number of properties with marginal zone
(MZ) B cells, which reside in the region surrounding the marginal
sinuses of splenic lymphoid follicles and therefore have immediate
contact with blood-borne Ags (12). Both B-1 and MZ B cells have
a restricted BCR repertoire, produce Abs in response to thymus-
independent type 2 (TI-2) Ags, and neither of both proliferate in
response to BCR cross-linking (11–13).
Studies using transgenic (tg) and gene-deficient animals have
shown that B cell fate depends on the type and strength of the BCR
signal. Disruption of BCR signaling affects maturation of splenic B
cells and the peritoneal B1 population (reviewed in Ref. 14). In
contrast, the MZ B cell population appears to be less sensitive to
impaired BCR signaling. Rather, a reduction in MZ B cells is
found in some gene-deficient mice, which show increased BCR
signaling (15, 16). Other processes such as chemokine receptor
triggering and expression of adhesion molecules also affect the MZ
population (12, 17). These properties indicate that B-1 and MZ
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cells, although sharing a number of common functional properties,
are individual sets of B lymphocytes, which are regulated by spe-
cific signals.
The identification of NFATc1 as an important regulator of de-
velopment of murine B-1a cells (8) prompted us to investigate
whether its relatives, NFATc2 and c3, which are also expressed in
peripheral B lymphocytes, might have similar important functions
on B cell development. We show here that in mice double-deficient
for NFATc2/c3, MZ B cells are underrepresented, whereas mature
follicular B cells are strongly increased in numbers. Upon BCR
stimulation, B cells from NFATc2/c3/ mice show a distinct in-
crease in Ca2 mobilization and proliferation. However, chimeric
mice reconstituted with NFATc2/c3/ B cells show a normal
number of MZ B cells and a normal B cell responsiveness. These
data suggest a differential response of MZ and follicular B cells to




NFATc2/c3 double-deficient mice (BALB/c background) (18) or control
mice (either wild-type or NFATc2/c3/ mice, always littermates or
matched age from similar matings) of 7–10 wk of age were used in all
experiments.
Flow cytometry
Single-cell suspensions of BM cells or splenocytes (after isotonic erythro-
cyte lysis) or directly isolated peritoneal lavage cells were incubated for 30
min at 4°C with different combinations of the following Abs: anti-B220-
biotin, anti-B220-FITC, anti-IgD-FITC, anti-CD21-FITC, anti-IgM-FITC,
anti-IgM-PE, anti-CD23-PE, and anti-CD5-PE (all from BD Pharmingen).
To block the FcRII receptor, stainings were performed in PBS containing
0.1% BSA (Roche Diagnostic Systems), 0.1% Na-azide, and saturating
concentration of anti-CD16/CD32 (BD Pharmingen). Biotin-labeled Ab
was revealed by streptavidin-cychrome (BD Pharmingen) in a second
staining step. Cell surface marker expression was analyzed using a four-
color flow cytometer (FACSCalibur) and CellQuest software (BD
Biosciences).
Histology
Spleen sections were stained with the same Abs as published previously
(16). For trinitrophenyl (TNP)-Ficoll-capturing assays, 9-wk-old control or
NFATc2/c3/ mice were injected with 100 g of TNP-Ficoll (Biosearch
Technologies) in 500 l of PBS i.v. Mice were sacrificed 30 min later, and
spleens were isolated.
Ca2 measurements
Splenocytes were loaded with indo-1 as previously described (19) and
stained extracellularly with anti-Mac1-FITC and anti-CD5-PE (BD Pharm-
ingen). Ca2 movement was measured upon stimulation of splenocytes
with B7.6 anti-IgM Ab at 37°C. Increases in intracellular-free Ca2 of B
cells were measured in real time using FACSVantage equipment (BD Bio-
sciences) by gating on Mac1- and CD5-negative B cells. The recorded files
were transferred to FlowJo software, and the median of each sample was
calculated and analyzed in overlays.
Proliferation assays
Splenocytes from animals indicated were T cell depleted by pretreating the
cells with anti-CD4 and anti-CD8 mAbs (IgM isotypes) on ice followed by
incubation with baby rabbit complement (Cedarlane Laboratories) for 45
min at 37°C afterward. For stimulation, 1  105 B cells in RPMI 1640
medium containing 5% FCS were stimulated for 48 h with a different
concentration of LPS (Calbiochem), anti-IgM F(ab)2 (The Jackson Lab-
oratory), B7-6 (monoclonal anti-IgM, our hybridoma collection), anti-
CD40 (BD Pharmingen), or IL-4 (200 U/ml). Proliferation was measured
by [3H]thymidine incorporation (1 Ci/well) during the last 8 h of culture.
TNP-Ficoll immunization and ELISA
Mice of 8–10 wk of age were immunized with 10 g of TNP-Ficoll (Bio-
search Technologies) and bled on days 0, 5, and 7. The TNP-specific Abs
in sera were determined by ELISA with TNP-BSA-coated polysorb plates
as described previously (20).
Adoptive transfer experiments
For BM reconstitution experiments, MT recipient mice (on BALB/c
background) (21) were irradiated sublethally twice with 3.5 Gy (with a 2-h
interval between the two irradiations). After a rest for 24 h, 2  106 BM
cells of NFATc2/c3/  DO11.10 tg and DO11.10 tg control donor mice
(both on BALB/c background) were injected into each recipient i.v. (four
mice per group). At day 32 after repopulation, the animals were sacrificed,
and spleen cells were prepared for FACS, histology, and proliferation as-
says. The reconstitution of the B cell compartment was analyzed from
blood cells with anti-IgM and anti-B220 Abs, and the contribution of trans-
ferred tg T cells to the recipient T cell compartment was determined using
the Id-specific anti TCR KJ1–26 (22).
Results
To investigate whether NFATc2 and NFATc3 play a role in B cell
differentiation, B cells from NFATc2/c3 double-deficient mice
were analyzed by flow cytometry. In the BM, B cell development
FIGURE 1. NFATc2/3 double de-
ficiency does not affect composition
of B cell populations in BM and peri-
toneal cavity. A, Stainings of BM
cells from control mice and
NFATc2/c3 double-deficient (dko)
mice with anti-IgM and anti-B220
mAb (total life cells) are shown on
the left. On the right, total BM cell
numbers and numbers of B220 cells
are presented. There is a reduction in
B220 cells and an increase in num-
ber of non-B lineage cells in BM. B,
Peritoneal lavage cells are stained
with anti-IgM and anti-CD5 Abs. No
significant change is found in relative
numbers of B-1a B cells (B1a) or
conventional B-2 B cells (boxed to-
gether with B-1b B cells (B1b)). Sig-
nificance was determined by Stu-
dent’s t test with four mice per group.
, p  0.05.
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appeared to be normal, i.e., pro-/pre-B cells and immature B cells,
and mature B cells were found in normal relative proportions (Fig.
1A). However, because of the massive expansion of granulocytes
and eosinophils in NFATc2/c3 double-deficient mice (18), a de-
crease was detected in the total number of B lineage cells (B220)
in BM (Fig. 1A). Additional stainings of CD43, BP-1, CD23, and
IgD markers did not reveal any additional changes in BM B cell
development (data not shown). Similarly, the population of B-1 B
cells from peritoneal cavity, which is strongly reduced in NFATc1-
deficient mice (8), appeared to be normal in NFATc2/c3 double-
deficient mice. In FACS analyses, a slight but not significant rel-
ative decrease in B-1a cells (identified as CD5lowIgM) from
NFATc2/c3/ mice was detected, when compared with control
mice, whereas the population of CD5IgM B cells (mainly con-
ventional B2 but also containing the minor population of B-1b
cells) was slightly increased in relative numbers (Fig. 1B).
NFATc2/c3 double-deficient mice develop a massive spleno-
megaly (18). By analyzing the splenic B cell compartment from 6-
to 8-wk-old mice, we observed 4-fold increased total numbers of
B cells. Interestingly, this increase differently affected distinct B
cell populations. Mature B cells, identified as CD21medIgMlow
cells, were 4-fold and increased in number (Fig. 2A), whereas the
immature populations, transitional type 1 (T1) and transitional type
2 (T2) B cells (23), remained unaffected. This resulted in a relative
2-fold decrease of T1 and T2 cells, as compared with control an-
imals (Fig. 2A). The relative reduction in T1 and T2 cells was also
confirmed in IgM/IgD stainings (data not shown).
The population of CD21highIgMhigh cells also contains MZ B
cells, and this B cell subpopulation was identified with mAbs
against CD23 and CD21. CD21highCD23lo-neg MZ B cells were
found to be 3-fold reduced in relative numbers but, due to a large
increase in total splenic B cells, were almost identical in total cell
numbers (Fig. 2B). Also, when splenic B cells were stained for the
MZ B cell marker CD1d, a 3-fold underrepresentation was de-
tected for MZ CD1d B cells in spleens from NFATc2/c3 double-
deficient mice (Fig. 2C). The reduction in MZ B cells was also
confirmed in histological stainings. Using anti-MOMA and anti-
IgM Abs, fewer IgM cells were detected in the MZ outside of the
marginal sinus in spleen sections from NFATc2/c3/ mice, com-
pared with those from wild-type mice (Fig. 2D).
We next examined the responses of NFATc2/c3/ B cells after
BCR triggering. Upon stimulation with 20 g/ml anti-IgM Ab,
splenic B cells from NFATc2/c3/ mice showed a pronounced
increase in Ca2 mobilization, compared with B cells from control
mice (Fig. 3A). This increase in Ca2 levels was also detected after
stimulation with lower anti-IgM Ab concentrations (data not
shown). Likewise, isolated splenic B cells were stimulated with
various mitotic stimuli, and the proliferative responses were mea-
sured. Strongly increased proliferative responses of NFATc2/c3
double-deficient B cells were found in response to anti-IgM Abs,
as well as with other stimuli (Fig. 3B). More moderate but still
significantly increased proliferation rates were also determined for
B cells from NFATc2/ or NFATc3/ single-deficient mice,
relative to wild-type control littermates (data not shown).
MZ B cells are known to participate in responses to TI-2 Ags.
It has been shown that i.v.-injected TNP-ficoll is captured initially
by MZ B cells but not by follicular B cells (24, 25). To study this,
TNP-Ficoll was injected i.v., mice were sacrificed 30 min later,
and spleen sections were stained with anti-TNP and anti-MOMA
Abs. As shown in Fig. 4A, numerous MZ B cells from wild-type
mice could efficiently capture TNP-Ficoll, whereas much less
NFATc2/c3/ B cells were observed to capture TNP-Ficoll (Fig.
FIGURE 2. NFATc2/c3 double-deficient (dko)
mice show a selective reduction in MZ B cells and in
immature, transitional B cells in the spleen. A,
Splenic cells were stained by anti-IgM/anti-CD21
Ab. A relative reduction in both T1 and T2/MZ B
cells from NFATc2/c3 dko mice is detected, as
shown in the middle panel. The total cell numbers
for T1, T2/MZ, and mature (M) B cells are shown in
the right panel. B, Stainings with anti-CD21/anti-
CD23 Abs revealed a relative reduction in MZ B
cells, whereas follicular (FO) B cells are unaffected
(left and middle panels). The right panel shows total
cell numbers. C, Staining using anti-B220 and anti-
CD1d Abs indicates an underrepresentation of MZ B
cells in NFATc2/c3 dko mice. D, Histological sec-
tions of spleens from NFATc2/c3 dko mice show a
reduced population of IgM cells (stained in red
with anti-IgM) in MZ. Staining in green was done
with anti-MOMA-1 Ab, which is specific for metal-
lophilic macrophages that separate the MZ from the
follicle. Sections were viewed under 400 magni-
fication. Significance was determined by Student‘s t
test from three to five mice per group. , p  0.05;
, p  0.01.
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4A). The rare NFATc2/c3/ B cells binding TNP-Ficoll were
found both in the MZ and in the follicle (Fig. 4A). Subsequently,
the Ig response to i.p.-injected TNP-Ficoll was measured in sera of
both types of mice. Although NFATc2/c3/ mice showed in-
creased TNP-specific Ig levels before immunization, they elicited
a similar increase in levels of TNP-specific IgM and IgG3 at days
5 and 7 postimmunization, compared with control mice (Fig. 4B).
This indicates that NATc2/c3 double-deficient mice can mount
normal TI-2 responses, although they show a relative reduction in
MZ B cells per follicle.
To determine whether the reduction in MZ B cells is an intrinsic
B cell defect, adoptive transfer experiments were performed. B
cell-deficient MT mice (21) were irradiated sublethally and re-
constituted with BM cells from NFATc2/c3/ or control mice.
For the identification of donor T cells generated from transferred
BM, DO11.10 tg wild-type or DO11.10 tg NFATc2/c3/ mice
were used as donors. Their genetic background allows the detec-
tion of transferred T cells with an idiotypic anti-TCR Ab. Before
transfer (1.), we confirmed that DO11.10 tg mice exhibit a similar
defect in MZ B cells as NFATc2/c3/ mice (data not shown), and
(2.) we tested conditions, i.e., the x-ray dose given to MT recip-
ient mice and the cell number used for i.v. injections, under which
donor T cells contribute poorly to the T cell compartment of re-
cipient mice. When mice were analyzed at day 32 after cell trans-
fer, we found that 10% of T cells but all B cells were found to
be donor derived (data not shown). However, when the B cell
compartment of the reconstituted MT mice was analyzed, we did
not detect any reduction in MZ B cell population. Both types of
mice, either reconstituted with wild-type DO11.10 or with
NFATc2/c3/ DO11.10 BM cells, showed a similar relative
number of MZ B cells (Fig. 5, A–C) and of transitional and mature
B cells (data not shown). Likewise, the proliferative responses of
B cells from both types of reconstituted mice were identical (Fig.
5D). These results indicate that the B cell defects and changes in
B cell responsiveness of NFATc2/c3 double-deficient mice are not
cell-autonomous but must be due to extrinsic factors.
Discussion
The experimental data presented here and those of other authors
(8) suggest that NFAT factors play a minor, if any, role in early B
cell development in BM. However, distinct functional roles of
NFAT factors have been identified for the generation and function
of peripheral B cell populations. Although NFATc1 is critical for
the development of B-1a cells (8), NFATc2/c3/ mice show an
altered composition of the splenic B cell compartment, i.e., an
underrepresentation of both MZ B cells and transitional B cells and
a relative increase in mature follicular B cells. However, these
changes are not B cell intrinsic, as we have shown by adoptive
transfer experiments using MT recipient mice.
Similarly to NFATc2/c3/ T cells, B cells from NFATc2/
c3/ mice show a hyperresponsiveness to Ag receptor stimula-
tion. This not only leads to increased proliferative responses but
also to an increased Ca2 mobilization. The hyperresponsiveness
FIGURE 3. Enhanced Ca2 mobilization and proliferation of NFATc2/
c3/ B cells. A, Splenocytes from control mice (dotted line) and
NFATc2/c3 double-deficient (dko) mice (bold line) were stimulated with
20 g/ml B7-6 (anti-IgM) at the time point indicated by an arrow. B cells
were gated (as CD5,Mac-1), and the ratio of bound to unbound indo-1
was determined. Intracellular Ca2 concentration is proportional to the
ratio of bound to unbound indo-1. B, Splenic B cells of mice indicated were
cultured for 48 h with the stimuli shown, and [3H]thymidine incorporation
was measured. Means of triplet measurements plus SD are shown. One of
three typical assay experiments is shown.
FIGURE 4. NFATc2/c3 double-deficient (dko) mice show a reduction
in TNP-Ficoll-binding cells in the MZ but mount normal Ig responses to
TNP-Ficoll immunization. A, Spleen sections from mice, 30 min after i.v.
injection of TNP-Ficoll, were stained with biotin-labeled anti-TNP Abs
(red) and FITC-labeled anti-MOMA-1 Abs (green). Biotinylated Ab was
revealed with streptavidin-cychrome. Sections were mounted with Moviol
containing DNA-specific fluorescent dye 4,6-diamidino-2-phenylindole
(blue), which stains all cell nuclei. Sections were viewed under 400 mag-
nification. B, Control and NFATc2/c3 dko mice were immunized with
TNP-Ficoll at day 0, and TNP-specific IgM and IgG3 responses were de-
termined by ELISA at days 5 and 7 postimmunization. One of two (for A)
and of three (for B) typical assay experiments is shown.
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of B cells from NFATc2/c3/ mice is not cell-autonomous but
affected by extrinsic factors. This was evident from the adoptive
transfer experiments, in which B cells derived from NFATc2/c3-
deficient donor BM showed a normal proliferative response in re-
cipients with (mainly) wild-type T cells. Most likely the extrinsic
factors in NFATc2/c3/ mice are strongly elevated levels of Th2-
type cytokines, which lead to highly increased serum levels of
IgG1 and IgE (18). This increased Th2 cytokine milieu not only
affects class switching but also the BCR responsiveness of B cells.
In accordance with this, activation markers, such as MHC class II
or B7-2, were found to be up-regulated on NFATc2/c3/ B cells
(Ref. 18 and our results). Alternatively, it cannot be excluded that
cells other than, or in addition to, T cells are affected by the
NFATc2/c3 deficiency and mediate the hyperresponsive pheno-
type of B lymphocytes.
Because B cells from NFATc2/c3/ mice are hyperresponsive
in vitro, they probably also show an increased BCR signaling in
vivo. The strength of BCR signals can determine the fate of pe-
ripheral B cells (14). This has been demonstrated recently in mice
in which a BCR surrogate, e.g., the LMP2A protein from EBV,
was found to determine the fate of B cells in different ways, de-
pending on its surface expression level and the resulting signaling
strength (26). In addition, mice deficient for CD22 (16) or the
transcription factor Aiolos (15), which show increased B cell sig-
naling, exhibit a reduced number in MZ B cells and transitional B
cells and a relative increase in mature B cells. A similar phenotype
was found in NFATc2/c3 double-deficient mice. Therefore, the
reduced population of MZ B cells in NFATc2/c3/ mice might
be caused by the preactivated state and increased BCR signaling of
their B cells.
This increased BCR signaling could affect MZ B cell develop-
ment or MZ B cell proliferation directly. In vitro, MZ B cells do
not show proliferative responses after BCR stimulation, in contrast
to follicular B cells (27). Thus, the increased BCR signaling of
NFATc2/c3/ mice could selectively expand mature follicular B
cells in vivo. The hyperactivated state of B cells could also affect
the responsiveness of B cells against chemokines and their migra-
tion to the MZ. This view is supported by the defects in the MZ B
cell compartment observed upon inactivation of integrins LFA-1
and 41 (17) and upon impairment of chemokine receptor sig-
naling (25). Alternatively, the Th2 cytokine milieu or other factors
may cause indirect affects on other cells of the MZ, which affect
migration of B cells. Such cells could be MZ macrophages, which
appear to control the trafficking and retention of B cells in the MZ
(28). Because the critical chemokine for placement of B cells in the
MZ is not known, these different possible mechanisms are hard to
study experimentally.
FIGURE 5. B cell-deficient mice reconstituted
with BM cells from control or NFAT c2/c3 double-
deficient (dko) mice lack differences in MZ B cell
compartment and in proliferative B cell responses.
A–C, B cell-deficient MT mice were irradiated
sublethally and reconstituted with BM cells from
control DO11.10 tg or NFAT c2/c3 dko/DO11.10 tg
BM cells. The DO11.10 background of transferred T
cells was identified to be 10% using KJ126 Ab. As
shown in A–C, reconstituted mice with B cells de-
rived from control or DO11.10 tg BM display a sim-
ilar number of MZ B cells. Histological stainings
were done as in Fig. 1. D, Proliferate responses of
purified splenic B cells from both types of mice for
various stimuli are shown (for details see Fig. 3B).
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NFATc2/c3-deficient mice mounted normal Ig responses to im-
munization with a TI-2 Ag. Therefore, the MZ B cells, which are
present in NFATc2/c3/ mice, are functional. Although there is
a reduction in functional MZ B cells per follicle, as indicated by
reduced numbers of IgM MZ cells and reduced TNP-Ficoll-cap-
turing cells in histological sections, the massive expansion of
splenocytes probably leads to an increased number of follicles and
therefore, overall, to a similar TI-2 response. The high number of
follicular B cells could also lead to a stronger contribution of fol-
licular B cells to TI-2 responses in NFATc2/c3/ mice than nor-
mally found.
Taken together, the data presented here on function of NFAT
transcription factors in B cells indicate that NFATc2/c3 deficiency
leads to B cell hyperresponsiveness toward BCR-induced signals
by an indirect mechanism and to underrepresentation of MZ B
cells. Thus, the data support the view that MZ B cells differ from
conventional B cells in their reaction to strong extrinsic signals
that drive normal B cells, but not MZ B cells, to proliferate.
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